Please assess the completion status of the following clinical trial:

Trial Title: Chloroquine for Treatment of Glioblastoma Multiforme

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Tumor restricted to one hemisphere of the brain~* Karnofsky scale \>7~* Histologically confirmed GBM in first or second recurrence or relapse~* Adequate hematologic, hepatic and renal function~* Karnofsky performance status score ≥ 70%~* Life expectancy ≥ 16 weeks~Exclusion Criteria:~* Gastrointestinal dysfunction~* Compromised cardiac function~* Concurrent severe and /or uncontrolled medical conditions

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: None

Based on this trial design, predict the completion outcome and termination type (if applicable).